glycyrrhizic acid has been researched along with Renal Insufficiency, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anders, HJ; Enghard, P; Harris, HE; Humphreys, BD; Iwakura, T; Klocke, J; Kuang, M; Li, C; Linkermann, A; Marschner, JA; Motrapu, M; Muto, Y; Popper, B; Romagnani, P; Zhao, ZB | 1 |
| Antoniv, A; Kanovska, L; Khukhlina, O; Mandryk, O; Smandych, V | 1 |
2 other study(ies) available for glycyrrhizic acid and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Tubular Epithelial Cell HMGB1 Promotes AKI-CKD Transition by Sensitizing Cycling Tubular Cells to Oxidative Stress: A Rationale for Targeting HMGB1 during AKI Recovery.
Topics: Acute Kidney Injury; Animals; Epithelial Cells; Glycyrrhizic Acid; HMGB1 Protein; Humans; Kidney; Mice; Oxidative Stress; Regeneration; Renal Insufficiency, Chronic | 2023 |
EFFECTIVENESS OF NONALCOHOLIC STEATOHEPATITIS CORRECTION ON THE BAСKGROUND OF OBESITY WITH CONCOMITANT CHRONIC KIDNEY DISEASE.
Topics: Administration, Oral; Anti-Inflammatory Agents; Cysteine; Drug Administration Schedule; Drug Combinations; Extracellular Matrix; Glycine; Glycyrrhizic Acid; Humans; Injections, Intravenous; Non-alcoholic Fatty Liver Disease; Obesity; Renal Insufficiency, Chronic; Treatment Outcome | 2018 |